Creative Biolabs highlights the growing importance of antibody engineering and conversion strategies in advancing ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug ...
Reviewed by Michael Greenwood, M.Sc. In phage-display, a gene encoding the surface protein of a bacteriophage is replaced with a gene encoding a novel protein. The technique can be used in drug ...
Phage display is an analytical technique used to study protein-protein interactions and the relationship between a protein and the encoding DNA. Phage display begins by incorporating the protein of ...
As bacteria become resistant to antibiotics, more people will become infected and die of untreatable bacterial infections. By 2050, drug-resistant infections are predicted to kill ten million people a ...
A phase II study of Epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin’s lymphomas No significant financial relationships to disclose. This is an ASCO Meeting ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the ...
A new film called Salt in My Soul was recently released, with one of the expressed goals being to raise funds for phage research and antibiotic resistance. Renewed interest in phage therapy began with ...
Company Promotes Use of Phage Display with Lipoparticles to Isolate Human Antibodies Integral membrane proteins such as GPCRs, ion channels, and transporters are a large family of proteins responsible ...
Adaptive Phage Therapeutics, a clinical-stage company that develops phage therapeutics to counter multidrug-resistant pathogenic bacteria, operates Biosafety Level 2 laboratories and phage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results